Privium Fund Management B.V. Ginkgo Bioworks Holdings, Inc. Transaction History

Privium Fund Management B.V.

  • $401 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 03, 2022
BUY
$0.73 - $3.74 $74,825 - $383,350
102,500 Added 136.67%
177,500 $556,000
Q2 2022

Jul 28, 2022
BUY
$2.2 - $4.2 $134,123 - $256,053
60,965 Added 434.38%
75,000 $179,000
Q1 2022

May 10, 2022
BUY
$2.83 - $8.69 $39,719 - $121,964
14,035 New
14,035 $57,000

Others Institutions Holding DNA

# of Institutions
40
Shares Held
48.1M
Call Options Held
0
Put Options Held
0
View Full List

About Ginkgo Bioworks Holdings, Inc.

DNA Quotes by TradingView
  • Ticker DNA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 1,287,779,968
  • Market Cap $12.1B
  • Description
  • Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...
More about DNA
Track This Portfolio

Track Privium Fund Management B.V. Portfolio

Follow Privium Fund Management B.V. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Privium Fund Management B.V., based on Form 13F filings with the SEC.

News

Stay updated on Privium Fund Management B.V. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email